Lenalidomide VISN 22 BPA
ID: 36C26226Q0097 • Type: Award Notice
• Match:
90%
Opportunity Assistant
Loading
Overview
Awardee
Award ID
36C26226A0006
Reported Award
$21,167,021
Award Date
Jan. 13, 2026
Posted
Jan. 13, 2026, 5:52 p.m. EST
Set Aside
None
Place of Performance
Not Provided
Source
Current SBA Size Standard
1300 Employees
Pricing
Likely Fixed Price
Vehicle Type
Blanket Purchase Agreement
Lenalidomide VISN 22 BPA (36C26226Q0097) was awarded to Exelan Pharmaceuticals on 1/13/26 by VISN 22: Desert Pacific Healthcare Network.
Primary Contact
Documents
Posted documents for Award Notice 36C26226Q0097
Question & Answer
The AI Q&A Assistant has moved to the bottom right of the page
Award Notifications
Agency published notification of awards for Award Notice 36C26226Q0097
IDV Awards
Indefinite delivery vehicles awarded through Award Notice 36C26226Q0097
Similar Active Opportunities
Open contract opportunities similar to Award Notice 36C26226Q0097
Experts for Lenalidomide VISN 22 BPA
Recommended subject matter experts available for hire
Additional Details
Source Agency Hierarchy
VETERANS AFFAIRS, DEPARTMENT OF > VETERANS AFFAIRS, DEPARTMENT OF > 262-NETWORK CONTRACT OFFICE 22L (36C262)
FPDS Organization Code
3600-00262
Source Organization Code
100173469
Last Updated
Jan. 13, 2026
Last Updated By
hestia.sim@va.gov
Archive Date
Feb. 12, 2026